Pictet Asset Management Holding SA Increases Holdings in GRAIL, Inc. $GRAL

Pictet Asset Management Holding SA grew its position in shares of GRAIL, Inc. (NASDAQ:GRAL) by 1,036.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,926 shares of the company’s stock after buying an additional 37,326 shares during the quarter. Pictet Asset Management Holding SA’s holdings in GRAIL were worth $3,585,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. WIM INVESTMENT MANAGEMENT Ltd increased its position in GRAIL by 200.0% during the third quarter. WIM INVESTMENT MANAGEMENT Ltd now owns 63,000 shares of the company’s stock valued at $3,725,000 after acquiring an additional 42,000 shares during the last quarter. JPMorgan Chase & Co. boosted its position in GRAIL by 159.1% in the third quarter. JPMorgan Chase & Co. now owns 206,120 shares of the company’s stock worth $12,188,000 after purchasing an additional 126,576 shares during the last quarter. Farallon Capital Management LLC boosted its position in GRAIL by 168.7% in the third quarter. Farallon Capital Management LLC now owns 1,349,000 shares of the company’s stock worth $79,766,000 after purchasing an additional 847,000 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of GRAIL during the 3rd quarter valued at about $885,000. Finally, Trifecta Capital Advisors LLC increased its position in shares of GRAIL by 89.9% during the 3rd quarter. Trifecta Capital Advisors LLC now owns 21,650 shares of the company’s stock valued at $1,280,000 after purchasing an additional 10,250 shares during the last quarter.

Insiders Place Their Bets

In other news, CEO Robert P. Ragusa sold 123,502 shares of the stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total value of $6,165,219.84. Following the completion of the sale, the chief executive officer directly owned 518,582 shares of the company’s stock, valued at $25,887,613.44. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Aaron Freidin sold 45,806 shares of the firm’s stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total transaction of $2,286,635.52. Following the sale, the chief financial officer owned 260,669 shares in the company, valued at $13,012,596.48. The trade was a 14.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 310,267 shares of company stock worth $15,485,396 over the last three months.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on GRAL. TD Cowen upgraded shares of GRAIL from a “hold” rating to a “buy” rating and set a $65.00 price objective on the stock in a research note on Wednesday, March 18th. Mizuho began coverage on shares of GRAIL in a report on Friday, April 10th. They set a “neutral” rating and a $58.00 target price for the company. Robert W. Baird set a $82.00 price target on shares of GRAIL in a research report on Friday, February 20th. Wall Street Zen cut shares of GRAIL from a “hold” rating to a “sell” rating in a research note on Saturday, April 11th. Finally, Piper Sandler started coverage on shares of GRAIL in a research report on Friday, April 10th. They set a “neutral” rating and a $54.00 price objective for the company. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, GRAIL has a consensus rating of “Hold” and an average target price of $68.63.

GRAIL Price Performance

GRAL stock opened at $54.06 on Monday. GRAIL, Inc. has a twelve month low of $29.95 and a twelve month high of $118.84. The stock has a market cap of $2.32 billion, a P/E ratio of -4.84 and a beta of 3.03. The business’s 50-day moving average price is $50.32 and its 200-day moving average price is $78.86.

GRAIL (NASDAQ:GRAL) last released its earnings results on Thursday, February 19th. The company reported ($2.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.33) by $0.89. GRAIL had a negative net margin of 277.46% and a negative return on equity of 17.11%. The company had revenue of $43.60 million during the quarter, compared to analyst estimates of $43.33 million. On average, equities research analysts expect that GRAIL, Inc. will post -11.82 earnings per share for the current fiscal year.

GRAIL Profile

GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company’s platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.